Literature DB >> 27903925

Onyx extravasation during embolization of a brain arteriovenous malformation.

Hiroyuki Ikeda1, Hirotoshi Imamura1, Yuji Agawa1, Yukihiro Imai2, Shoichi Tani1, Hidemitsu Adachi1, Tatsuya Ishikawa1, Yohei Mineharu1, Nobuyuki Sakai1.   

Abstract

During Onyx embolization to treat brain arteriovenous malformation (AVM), carefully observing the penetration of Onyx to the nidus is important in order to avoid complications such as hemorrhage, ischemia, and difficulty with microcatheter removal. We encountered a case of Onyx extravasation during embolization of a cerebellar AVM confirmed by surgical resection and pathological analysis. The patient was a 44-year-old man with Spetzler-Martin grade I cerebellar AVM who underwent Onyx embolization prior to resection of the brain AVM. While injecting Onyx into the nidus using the "plug-and-push" technique, Onyx extravasation was observed. Onyx injection was paused and subsequently restarted, thereby allowing continuation of embolization. An oblate Onyx cast that was entirely covered in cerebellar tissue was removed during total resection of the AVM, performed the same day. The surgically removed oblate Onyx cast did not contain brain tissue or vessel wall, and immunohistochemical staining against glial fibrillary acidic protein (GFAP) showed Onyx penetration into GFAP-positive cerebellar tissue. Onyx extravasation was confirmed based on intraoperative findings during resection as well as pathological findings. The patient has been followed for four years postoperatively, and adverse events caused by Onyx extravasation have not been observed. Unexpected cast of Onyx, remote from the vascular architecture of the AVM, may represent an intra-parenchymal extravasation.

Entities:  

Keywords:  Onyx; arteriovenous malformation; embolization; extravasation

Mesh:

Substances:

Year:  2016        PMID: 27903925      PMCID: PMC5433598          DOI: 10.1177/1591019916680112

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  18 in total

1.  Midterm results of the transarterial use of Onyx in the treatment of persisting type II endoleaks after EVAR.

Authors:  M J Bosiers; A Schwindt; K P Donas; G Torsello
Journal:  J Cardiovasc Surg (Torino)       Date:  2013-08       Impact factor: 1.888

2.  A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model.

Authors:  J C Chaloupka; D C Huddle; J Alderman; S Fink; R Hammond; H V Vinters
Journal:  AJNR Am J Neuroradiol       Date:  1999-03       Impact factor: 3.825

3.  Transcatheter arterial embolization of acute gastrointestinal tumor hemorrhage with Onyx.

Authors:  C J Sun; C E Wang; Y H Wang; L L Xie; T H Liu; W C Ren
Journal:  Indian J Cancer       Date:  2015-02       Impact factor: 1.224

4.  Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects.

Authors:  W Weber; B Kis; R Siekmann; D Kuehne
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

Review 5.  Onyx: a unique neuroembolic agent.

Authors:  Michael Ayad; Eric Eskioglu; Robert A Mericle
Journal:  Expert Rev Med Devices       Date:  2006-11       Impact factor: 3.166

6.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

7.  Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients.

Authors:  Vasilios Katsaridis; Chrysanthi Papagiannaki; Enrico Aimar
Journal:  Neuroradiology       Date:  2008-04-12       Impact factor: 2.804

8.  Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation.

Authors:  Sabareesh Kumar Natarajan; Donald Born; Basavaraj Ghodke; Gavin W Britz; Laligam N Sekhar
Journal:  J Neurosurg       Date:  2009-07       Impact factor: 5.115

Review 9.  Onyx® in the management of cranial arteriovenous malformations.

Authors:  Jalal Jalaly; John Dalfino; Shaker A Mousa
Journal:  Expert Rev Med Devices       Date:  2013-07       Impact factor: 3.166

10.  Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model.

Authors:  J C Chaloupka; F Viñuela; H V Vinters; J Robert
Journal:  AJNR Am J Neuroradiol       Date:  1994-06       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.